Is CD4 Monitoring Needed Among Ugandan Clients Achieving a Virologic and Immunologic Response to Treatment?

作者
Steven James Reynolds,Joseph Bukulu Sempa,Agnes N Kiragga,Kevin Newell,Gertrude F. Nakigozi,Ronald Moses Galiwango,Ron H. Gray,Thomas C. Quinn,David Serwadda,Larry W. Chang
出处
期刊:Aids Patient Care and Stds [Mary Ann Liebert, Inc.]
卷期号:28 (11): 575-578 被引量:14
标识
DOI:10.1089/apc.2014.0086
摘要

It is unclear whether ongoing CD4 monitoring is needed following immunologic and virologic response to antiretroviral therapy (ART). We investigated the proportion of clients who achieved a virologic and immunologic response and then had a subsequent CD4 count <200 cells/μL despite continued virologic suppression. Included in this analysis were clients receiving ART through the Rakai Health Sciences Program between June 2004-May 2013 who achieved a CD4 ≥200 cells/μL and VL ≤400 copies/mL and who had three sets of CD4 and VL measurements (defined as a sequence) within a 390 day period. A CD4 decline was defined as any drop in CD4 count to <200 cells/μL during a period of viral suppression. A total of 1553 clients were included, 68% females, mean age of 35.5 years (SD 8.3), median baseline CD4 count 183 cells/μL (IQR 106-224). 43 (2.8%) clients developed CD4 declines, the majority, 32/43 (74%), among individuals whose initial CD4 was <300 cells/μL. Of the 43 clients with CD4 declines, 24 had an additional CD4 measurement and 20/24 (83%) achieved a CD4 ≥200 cell/μL on their next measurement (median 285 cells/μL; IQR 220-365). CD4 declines were significantly greater among those with lower CD4 at sequence initiation [adjusted hazard ratio (AHR) 4.3 (95% CI 2.1, 9.0) CD4 200-249 versus ≥350 cells/μL]. Clients who achieved an immunologic and virologic response to ART were unlikely to experience a subsequent CD4 count decline to <200 cells/μL, and among those experiencing a decline, the majority were transient in nature. Thus, ongoing CD4 monitoring could be omitted.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhiguoxin完成签到,获得积分10
刚刚
chai完成签到,获得积分10
1秒前
blinkals57发布了新的文献求助10
1秒前
haan完成签到,获得积分10
2秒前
哈哈完成签到 ,获得积分10
2秒前
liu发布了新的文献求助10
3秒前
4秒前
lx1199完成签到 ,获得积分10
5秒前
zhu完成签到,获得积分10
5秒前
小小怪发布了新的文献求助30
5秒前
如小美完成签到,获得积分10
7秒前
迟书问剑完成签到 ,获得积分10
7秒前
Nothing发布了新的文献求助10
7秒前
8秒前
孤独星月发布了新的文献求助10
8秒前
请我吃葡萄完成签到 ,获得积分10
8秒前
Maestro_S的应助被Pupupapa采纳,获得10
8秒前
周江阔发布了新的文献求助10
8秒前
8秒前
9秒前
9秒前
直率万声发布了新的文献求助10
10秒前
10秒前
桐桐的应助被健康的魔镜采纳,获得10
11秒前
绿地土狗完成签到,获得积分10
11秒前
ding的应助被nikola采纳,获得10
12秒前
科研通AI6.4的应助被筑梦之鱼采纳,获得10
12秒前
wxwx发布了新的文献求助10
13秒前
加油完成签到 ,获得积分10
15秒前
15秒前
16秒前
16秒前
18秒前
qiqi发布了新的文献求助10
19秒前
19秒前
wanci的应助被小小怪采纳,获得10
19秒前
wangbw发布了新的文献求助10
19秒前
20秒前
Pupupapa完成签到,获得积分20
20秒前
lulu完成签到,获得积分10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178807
求助须知:如何正确求助?哪些是违规求助? 9569558
关于积分的说明 21805222
捐赠科研通 7773974
什么是DOI,文献DOI怎么找? 3432933
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478593